Doctor Bethlehem Mengesha

University of Ottawa Heart Institute, Ottawa (Canada)

Membership: ESC Professional Member EACVI Member

Follow

Contributor content

Reversible P2Y12 inhibitor versus irreversible P2Y12 inhibitor in ACS patients undergoing PCI (the acute coronary syndrome israeli survey (ACSIS)

Presentation

Reversible P2Y12 inhibitor versus irreversible P2Y12 inhibitor in ACS patients undergoing PCI (the acute coronary syndrome israeli survey (ACSIS)

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources